존슨앤드존슨
$250.57-2.47시가총액
$632.3B
글로벌 순위
#21
역대 최고치
$643.3B
2026-07-07
총 성장률
+0%
2026년 이후
Market Cap Context
존슨앤드존슨 Financial Breakdown (FY 2025)
Source: Yahoo Finance — JNJ annual filings (2025) →$94.2B revenue · $25.6B operating income · $26.8B net income
- ●Operating margin: 27.2% on $94.2B in revenue.
- ●R&D is 15.6% of revenue ($14.7B).
- ●Net income margin: 28.5% — $26.8B in profit.
- ●Free cash flow: $19.3B (20.5% of revenue).
Cost / Operating Expenses
Total operating expenses $68.6B
Total
$68.6B
Capital Expenditures
$5.2B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$19.3B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Fundamentals (TTM)
Data: Financial Modeling PrepP/E
28.9
EPS
$8.60
Net margin
21.8%
ROE
26.3%
Dividend yield
2.09%
Debt / Equity
0.68
존슨앤드존슨 소개
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey. The company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Along with Microsoft, Johnson & Johnson is one of only two U.S.-based companies that has a prime credit rating of AAA from S&P Global.
존슨앤드존슨 시가총액 추이 (2026–2026)
존슨앤드존슨 vs Sector Peers by Market Cap
존슨앤드존슨 비교
순위 추이
| 연도 | 시가총액 | 순위 | 전년 대비 변화 |
|---|---|---|---|
| 2026 | $632.3B | #21(↓1) | +28.3% |
| 2025 | $492.7B | #20(↑5) | +47.5% |
| 2024 | $334.1B | #25(↓5) | -4.8% |
| 2023 | $351.0B | #20(↓10) | -8.6% |
| 2022 | $383.9B | #10(↑5) | +6.0% |
| 2021 | $362.3B | #15(↓1) | +11.4% |
| 2020 | $325.1B | #14(↓1) | +10.8% |
| 2019 | $293.3B | #13(↓4) | +16.2% |
| 2018 | $252.4B | #9 | -5.1% |
| 2017 | $266.0B | #9(↓1) | +24.4% |
| 2016 | $213.8B | #8(↓1) | +15.3% |
| 2015 | $185.4B | #7(↓1) | +1.1% |
| 2014 | $183.3B | #6(↑2) | +17.3% |
| 2013 | $156.2B | #8(↑1) | +34.6% |
| 2012 | $116.0B | #9(↓2) | +10.8% |
| 2011 | $104.7B | #7(↑3) | +9.9% |
| 2010 | $95.3B | #10(↓6) | -0.6% |
| 2009 | $95.8B | #4(↑3) | +11.3% |
| 2008 | $86.1B | #7(↑5) | -7.7% |
| 2007 | $93.3B | #12(↓4) | +3.6% |
| 2006 | $90.1B | #8(↑1) | +12.4% |
| 2005 | $80.1B | #9 | -3.4% |
| 2004 | $82.9B | #9(↑2) | +25.2% |
| 2003 | $66.2B | #11(↓3) | -2.1% |
| 2002 | $67.6B | #8(↑3) | -7.9% |
| 2001 | $73.4B | #11(↑4) | +14.0% |
| 2000 | $64.4B | #15(↑3) | +14.2% |
| 1999 | $56.4B | #18(↓2) | +12.5% |
| 1998 | $50.1B | #16(↑1) | +29.0% |
| 1997 | $38.9B | #17(↓1) | +34.3% |
| 1996 | $28.9B | #16(↓4) | +18.1% |
| 1995 | $24.5B | #12(↑3) | +59.1% |
| 1994 | $15.4B | #15 |
기타 헬스케어 기업
자주 묻는 질문
What is Johnson & Johnson's market cap?
Johnson & Johnson (JNJ) has a market capitalization of $632.3B, making it the #21 largest company in the world by market cap.
What was Johnson & Johnson's highest market cap?
Johnson & Johnson's all-time high market cap was $643.3B, reached in 2026-07-07. Its highest rank was #21 in 2026.
What sector is Johnson & Johnson in?
Johnson & Johnson is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in United States.
How has Johnson & Johnson's market cap changed over time?
Johnson & Johnson has been tracked since 2026. Its market cap has grown by 0% from $632.3B in 2026 to $632.3B today.